Parallel Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-92,323
| Closed | -$281K | – | 3710 |
|
|
2024
Q4 | $281K | Hold |
92,323
| – | – | 0.01% | 786 |
|
|
2024
Q3 | $479K | Hold |
92,323
| – | – | 0.01% | 579 |
|
|
2024
Q2 | $237K | Buy |
+92,323
| New | +$237K | 0.01% | 798 |
|
|
2024
Q1 | – | Sell |
-327
| Closed | -$2.87K | – | 3423 |
|
|
2023
Q4 | $2.87K | Buy |
+327
| New | +$2.87K | ﹤0.01% | 2688 |
|
|
2023
Q2 | – | Sell |
-11
| Closed | -$354 | – | 3550 |
|
|
2023
Q1 | $354 | Buy |
+11
| New | +$354 | ﹤0.01% | 3209 |
|
|
2022
Q1 | – | Sell |
-308
| Closed | -$5K | – | 3331 |
|
|
2021
Q4 | $5K | Sell |
308
-2,045
| -87% | -$33.2K | ﹤0.01% | 2425 |
|
|
2021
Q3 | $66K | Buy |
2,353
+163
| +7% | +$4.57K | ﹤0.01% | 1147 |
|
|
2021
Q2 | $65K | Buy |
+2,190
| New | +$65K | ﹤0.01% | 1106 |
|
|
2020
Q4 | – | Sell |
-383
| Closed | -$10K | – | 2741 |
|
|
2020
Q3 | $10K | Hold |
383
| – | – | ﹤0.01% | 1736 |
|
|
2020
Q2 | $9K | Hold |
383
| – | – | ﹤0.01% | 1772 |
|
|
2020
Q1 | $5K | Hold |
383
| – | – | ﹤0.01% | 1922 |
|
|
2019
Q4 | $6K | Hold |
383
| – | – | ﹤0.01% | 1926 |
|
|
2019
Q3 | $5K | Buy |
383
+230
| +150% | +$3K | ﹤0.01% | 1937 |
|
|
2019
Q2 | $2K | Buy |
+153
| New | +$2K | ﹤0.01% | 2124 |
|